CHAPITRE VI. RÉFÉRENCES BIBLIOGRAPHIQUES

CHAPITRE VI.

RÉFÉRENCES BIBLIOGRAPHIQUES

1. Aida C. Mallillin, Trinidad P, Trinidad, Rosario S. Sagum, Marco P. de Leon, Mellissa P. Borlagdan, Amster Fei P. Baquiran, James S. Alcantara, Theresa F. Aviles. Mineral Availability and Dietary Fiber Characteristics of Moringa oleifera, Food and Public Health, 2014; 4 (5): 242 – 246.

2. Aïssi A.K, Kougblénou S, Dougnon T.V, Tchiakpe E, Bankolé H, Klotoé J.R., Edorh A.P. and Loko F. Evaluation de la qualité sanitaire des poudres de feuilles de Moringa oleifera Lam. Commercialisées au profit des Personnes Vivant avec le VIH à Cotonou (Bénin). International Journal of Biological and Chemical Sciences. 2013;(7): 1461- 1473.

3. . Ahoua L, Umutoni C, Huerga H, Minetti H, Szumilin, Balkan S, Olson D M, Nicholas S, Pujades-Rodríguez M, Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study, Journal of the International AIDS Society. 2011; 14:2.

4. ANAPI [Page consultée le 26 janvier 2015]- 53.54. ANAPI -Agence Nationale pour la Promotion des Investissements, Secteur des infrastructures. [Disponible sur internet] : https://www.investindrc.cd/fr/spip.php?article12.

5. Anselme Nkinsi, les feuilles de Moringa sauvent des vies. [Page consultée le 15 juillet 2014 ]. [ Disponible sur internet]: http://ipsinternational.org/fr/_note.asp?idnews=7050 6. Anwar F., Latif S., Ashraf M., Gilani AH., Moringa oleifera: a food plant with multiple

medicinal uses. Phytother Res. 2007; 21(1): 17-25.

7. Arasheski KE, Zachwieja JJ, Gischler J, Crowley J, Horgan MM, Powderly WG.

Increased plasma Gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting. Am J Physiol 1998; 275:577- 83.

8. Avert HIV-time line [Page consultée le 29 septembre 2017]. [Disponible sur internet] :

https://timeline.avert.org/?152/Sub-Saharan-Africa%E2%80%99s-burden-

9. Baden, S, & Wach H. Gender, HIV/AIDS transmission and impacts: review of issues and evidence. Briefing prepared for Swedish International Development Cooperation Agency (SIDA), Bridge development-gender report number 47. Institute of Development Studies, Brighton, England, 1998.

10. Bahwere, Chidiac S., Hammond W., Rumanya W., Thompson J., Technical Assistance Options to Support Food Security, Nutrition, and HIV Activities Using PEPFAR Resources in the Democratic Republic of the Congo, 2011.[Page consultée le 15 janvier 2015]. [Disponible sur internet]: http://theliftproject.org/wp- content/uploads/2013/04/FANTA-2-and-LIFT-DRC-Assessment-TA-Final.pdf.

11. Bahwere P, Deconinck H, Banda T, Collins S, effective Therapeutic Feeding with Chickpea Sesame Based Ready-to-Use Therapeutic Food (CS-RUTF) in Wasted Adults with Confirmed or Suspected AIDS, World Journal of AIDS, 2011; 1: 169-181.

12. Banque mondiale, Donnée de la République démocratique du Congo. [Page consultée le 21 janvier 2014]. [Disponible sur internet]: http://donnees.banquemondiale.org/pays/CD.

13. Batterham MJ, Investigating heterogeneity in studies of resting energy expenditure in persons with HIV/AIDS: a meta-analysis, Am J Clin Nutr. 2005 Mar; 81 (3):702-13.

14. Barré-Sinoussi F and Lewin S. [Page consultée le 13 avril 2015]. AIDS International AIDS 2014, the guardian.com, Monday 21 July 2014 01.40 BST. [Disponible sur internet]: https://www.theguardian.com/commentisfree/2014/jul/21/a-proof-of-concept- for-an-hiv-cure-exists-now-even-our-setbacks-are-useful.

15. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L.Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (Aids). Science. 1983 ; 220(4599):868-71.

16. Béjanin, F., Milleliri, J., Kuvula, J., & Manzengo, C. Rapport de la mission d’évaluation du Round 3 du Fonds Mondial, Composante VIH/sida. République Démocratique du Congo, OMS Bureau Afrique, 2011.

17. Berhe N, Tegabu D, Alemayehu M. Effect of nutritional factors on adherence to

antiretroviral therapy among HIV-infected adults: a casa control study in Northern

Ethiopia. BMC Infectious Diseases. 2013; 13:233.

18. Black RE, Allen LH, Bhutta Z A, Caulfield LE, Onis M, Ezzati M, Mathers C, Rivera J, for the Maternal and Child Undernutrition Study Group, Maternal and child under nutrition: global and regional exposures and health consequences. The lancet.2008; 9608 (371): 243-260.

19. Bonnard P. HIV/AIDS mitigation: using what we already know. Technical Note No. 5.

Food and Nutrition Technical Assistance Project, Academy for Educational Development, Washington, DC, 2002.

20. Borges Teixeiraa EM, Barbieri Carvalhob MR, Nevesa VA, Apareci MS, Arantes- Pereirac L, Chemical characteristics and fractionation of proteins from Moringa oleifera Lam. Leaves. Food Chemistry. 2014:147, 51–54.

21. Bose, S., Varanasi, A., & Mo, G. Demographic, socio-economic and psychological determinants of HIV treatment: A community out-patient experience. British Journal of Medical Practitioners. 2009; 2 (2):42- 45.

22. Bradshaw D. Dorrington R. Laubscher R. Rapid mortality surveillance report 2011.

Cape Town, South African Medical Research Council. 2012.

23. Bowie C, Kalilani L., Marsh R, Misiri H, Cleary P, Bowie C. An assessment of food supplementation to chronically sick patients receiving home based care in Bangwe, Malawi: a descriptive study. Nutrition Journal. 2005, 4:12.

24. Busani M, Masika P.J, Hugo A., Muchenje V, Nutrional characterization of Moringa (Moringa oleifera Lam.) leaves. African Journal of biotechnology. 2011; 60(10):12925 -33.

25. Briend A., Highly nutrient-dense spreads: a new approach to delivering multiple micronutrients to high-risk groups. Br J Nutr. 2001;85 (Suppl 2):S175-9.

26. Brisibe EA, Umoren UE., Brisibe F, Magalhaes PM, Ferreira JFS, Luthria D, Wu X, Prior RL. Nutritionnal characterization and antioxidant capacity of different tissues of Artemisia annua L. Food Chem. 2009; 115:1240-1246.

27. Broin M, The nutritional value of Moringa oleifera Lam. Leaves: what can we learn from figures? Moringanews Workshop. 2006. [Page consultée le 24 février 2015].

[Disponible sur internet] :

http://www.moringanews.org/doc/GB/Posters/Broin_poster.pdf.

28. Calza L. Renal toxicity associated with antiretroviral therapy. HIV Clin trials. 2012;

13(4): 189 - 211.

29. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, Stringer JS. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food insecure adults in Lusaka, Zambia, J Acquir Immune Defic Syndr. 2008: 49 (2).

30. Campbell EM, Hope TJ. Live cell imaging of the HIV-1 life cycle. Trends Microbiol.

2008 ;16: 580 - 587.

31. Chevalier Ph, Delpeuch F, Maire B, le complexe "malnutrition-infection" : premier problème de santé publique chez les populations défavorisées, Med Mal Infect.

1996;26:366 -70.

32. Cohen MS et al. Prevention of HIV-1 infection with antiretroviral therapy. New England Journal of Medicine. 2011, 365:493-505.

33. Collège des Enseignants de Nutrition. [Page consultée le 13 février 2012]. Collège des Enseignants de Nutrition. Évaluation de l’état nutritionnel. Cah. Nutr. Diét. 2001; (36), (hors série 1): 2S111- 2S116. [Disponible sur internet]: www.sf-nutrition.org/?

p=download&name=7&dossier.

34. Consolidated guidelines on the use of antiretroviral Drugs for treating and preventing HIV infection: Recommendations for a Public Health Approach, WHO, Juin 2013. [Page consultée le 13 novembre 2014]. [Disponible sur internet ]:

www.who.int/iris/bitstream/10665/85321/1/9789241505727eng.pdf.

35. Coppin J, a study of the nutritional and medicinal values of Moringa Oleifera leaves from sub-Saharan Africa: Ghana, Rwanda, Senegal and Zambia. A thesis submitted written under the direction of Dr. James Simon And Approved New Brunswick, New Jersey, May, 2008.

36. Dan Malam H. U, Abubakar Z, Katsayal U: Pharmacognostic studies on the leaves of Moringa oleifera. Nigerian Journal of Natural Product and Medicine. 2001;5: 45-49.

37. Dalziel, J.M. (1956): Useful plants of west tropical Africa. Crown Agents for Oversea

Government and Administration, London. 1956. 23pp.

38. De Herdt T, Marivoet W. and Marysse, S. Political Transition in DRC: How Did Kinshasa Households Fare? African Development Review. 2008; 20(3): 400–425.

39. De Pee S, Semba RD, Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings, Food Nutr Bull. 2010; 31(4): S313 - 44.

40. De Waal A, & Whiteside A. New variant famine: AIDS and food crisis in southern Africa. The Lancet. 2003; 362 (9391):1234 –1237.

41. De Walque D, Kazianga, H, Over M, Vaillant J. Food crisis, household welfare and HIV/AIDS treatment. The World Bank Development Research Group. 2011.

42. DHHS, [Page consultée le 17 décembre 2014]. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. [Disponible sur internet ]:

http://aidsinfo.nih.gov/guidelines.

43. Banque mondiale. [Page consultée le 02 mars 2015]. Donnée de la Banque mondiale sur la république Démocratique du Congo. [Disponible sur internet ] :

http://donnees.banquemondiale.org/pays/CD.

44. Dominique et Michèle Frémy, encyclopédie Quid 2001. 2000. Éditions Robert Laffont.

45. Donath MY, Immuno-métabolisme: un nouveau domaine avec des conséquences cliniques, Forum Med Suisse. 2014;14(5):80–82.

46. Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy. Am J Clin Nutr. 2007; 85(2):333 – 45.

47. Edward C, Klatt, MD, Pathology of AIDS, version 25, Mercer University, School of Medicine Savannah, may 7, 2014. [Page consultée le 18 février 2015]. [Disponible sur internet] : http://library.med.utah.edu/WebPath/AIDS2014.PDF.

48. Egger M, May M, Chêne G, Phillips A, Ledergerber B, Dabis F, Costagliola D,

D'Arminio M, de Wolf F, Reiss P, Lundgren J, Justice A, Staszewski S, Leport C, Hogg

R, Sabin C, Gill M, Salzberger B, Sterne J. Prognosis of HIV-1-infected patients starting

highly active antiretroviral therapy: a collaborative analysis of prospective studies. The

Lancet. 2002; 360(9327):119–129.

49. Emerman M, Malim MH. HIV-1 regulatory /accessory genes: keys to unraveling viral and host cell biology. Science. 1998. 280:1880 -1884.

50. Enquête Démographique et de Santé République Démocratique du Congo (EDS-RDC).

[Page consultée le 16 janvier 2015]. EDS-RDC, Ministère du Plan et Ministère de la Santé, 2007. [Disponible sur internet] :

www.dhsprogram.com/pubs/pdf/FR208/FR208.pdf.

51. Evans D, McNamara L, Maskew M, Selibas K, Van Amsterdam D, Baines N, Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy, Nutrition Journal.

2013;12:111.

52. FAO. [Page consultée le 15 mars 2015]. FAO, Food and Nutrition in numbers 2014.

[Disponible sur internet]: http://www.fao.org/3/a-i4175e.pdf.

53. FAO, IFAD and WFP, the State of Food Insecurity in the World 2014. Strengthening the enabling environment for food security and nutrition. Rome, FAO, 2014.

54. FAO. [Page consultée le 15 mars 2015]. FAO. le droit à l’alimentation, les directives volontaires à l’appui à la concrétisation progressive du droit à une alimentation adéquate dans le contexte de la sécurité alimentaire nationale, Adoptées à la cent vingt-septième session du Conseil de la FAO, Novembre 2004, Rome 2005. [Disponible sur internet]:

http://www.fao.org/3/a-y9825f.pdf.

55. Fahey J. W. M. oleifera: A Review of the Medical Evidence for Its Nutritional, Therapeutic, and Prophylactic properties. Part 1. Trees for Life Journal. 2005;1:5.

56. Fawzi WW, Msamanga GI, Hunter D, Renjifo B, Antelman G, Bang H, Manji K, Kapiga S, Mwakagile D, Essex M, Spiegelman D. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS.

2002;16 (14): 1935-44.

57. Ferrando SJ, Rabkin JG, Lin SH, McElhiney M. Increase in body cell mass and decrease

in wasting are associated with increasing potency of antiretroviral therapy for HIV

infection. AIDS Patient Care. 2005;19:216-223.

58. Fox, A. The social determinants of HIV serostatus in sub-Saharan Africa: an inverse relationship between poverty and HIV? Public Health Reports. 2010;125 (Suppl 4):16–

24.

59. Freiberger CE, Vanderjagt DJ, Pastuszyn A, Glew RS, Mounkaila G, Millson M, Glew RH. Nutrient content of the edible leaves of seven wild plants from Niger, Plant Foods Hum Nutr. 1998; 53(1):57- 69.

60. Fuglie LJ (1999) The Miracle Tree: Moringa oleifera: Natural Nutrition for the Tropics.

Church World Service, Dakar. 68 pp.; revised in 2001 and published as The Miracle Tree: The Multiple Attributes of Moringa. 2001:172.

61. Fylkesnes K, Musonda, R., Sichone, M., Ndhlovu, Z., Tembo, F., & Monze, M.

Declining HIV prevalence and risk behaviours in Zambia: evidence from surveillance and population-based surveys. AIDS, 15(7), 2001, pp. 907–916.

62. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science.

1984;224(4648):500 – 50.

63. Glynn J, Carael M, Buve A, Anagonou S, Zekeng L, Kahindo M, & Musonda R. Does increased general schooling protect against HIV infection?, A study in four African cities, Tropical Medicine and International Health. 2004;1(9): 4 – 14.

64. Gomez C, Hope TJ. The ins and outs of HIV replication. Cell Microbiol. 2005;7: 621- 626.

65. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50: 693 - 703.

66. Gothai S, Muniandy K, Zarin MA, Sean TW, Kumar S S, Munusamy MA, Fakurazi S, Arulselvan P. Chemical composition of Moringa oleifera ethyl acetate fraction and its biological activity in diabetic human dermal fibroblasts. Phcog Mag. 2017;13 (Suppl S3):462-9.

67. PNLS. [Page consultée le 10 décembre 2014] : Guide national de traitement de

l’infection à VIH par les antirétroviraux Version révisée avec l’appui de l’OMS et de

l’ONUSIDA, PNLS, janvier 2005. [Disponible sur internet]:

http://www.who.int/hiv/pub/guidelines/drc_art.pdf.

68. Grinspoon S., Mulligan K., Weight loss and wasting in patients infected with human Immunodeficiency virus, Clin. Infect. Dis. 2003; 36 (2): S69 - S78.

69. Grobler L, Siegfried N, Visser ME, Mahlungulu SSN, Volmink J, Nutritional interventions for reducing morbidity and mortality in people with HIV (Review), the Cochrane library. 2013:2.

70. Grunfeld C, Feingold KR., Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med.1992; 327: 329 - 37.

71. Hargreaves J, Bonell C, Boler T., Boccia D., Birdthistle I., Fletcher A., Pronyk P., &

Glynn J., Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS, 2008;22 (3): 403 – 414.

72. Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to AIDS. Science. 2006; (313): 462 - 466.

73. Herrero M, Thornton P.K, Notenbaert A.M, Wood S, Msangi S, Freeman H.A, Bossio, D, Dixon J, Peters, M., van de Steeg, J., Lynam, J., Parthasrathy Rao, P., Macmillan, S., Gerard, B., McDermott, J., Seré, C., Rosegrant, M., 2010. Smart investments in sustainable food production: revisiting mixed crop livestock systems. Science. 327: 822 – 825.

74. Heidari S, Abdool Karim Q, Auerbach JD, Buitendijk SE, Cahn P, Curno MJ, Hankins C, Katabira E, Kippax S, Marlink R, Marsh J, Marusic A, Nass HM, Montaner J, Pollitzer E, Ruiz-Cantero MT, Sherr L, Sow PS, Squires K, Wainberg MA, Gender- sensitive reporting in medical research, Journal of the International AIDS Soc. 2012;8;15 (1) :11.

75. Historique du VIH – publié sur le portal du VIH/SIDA du Québec. [Page consultée le 12 janvier 2015]. [Disponible sur internet] : http://www.pvsq.org/articles/historique.pdf.

76. HIV-1 Assay. [Page consultée le 26 mars 2012]. [Disponible sur internet]:

http://www.abbottmolecular.com/us/products/infectious-diseases/realtime-pcr/hiv-1-

assay.Html#indications-and-limitations.

77. Hoppe C, Andersen GS, Jacobsen S et al. the use of whey or skimmed milk powder in fortified blended foods for vulnerable groups. J Nutr. 2008; (138):145S - 61S.

78. Houtzager L M, Nutrition in HIV: A review, Journal of post graduate Medicine, 2009;

(11): 63-75.

79. Hsu JW, Pencharz PB, Macallan D, Tomkins A. Macronutrients and HIV/AIDS: A Review of Current Evidence in Consultation on Nutrition and HIV/AIDS in Africa:

Evidence, Lessons and Recommendations for Action. 2005. Durban, South Africa:

WHO, Department of Nutrition for Health and Development. [Page consultée le 10 janvier 2012]. [Disponible sur internet] :

http://www.who.int/nutrition/topics/PN1_Macronutrients_Durban.pdf.

80. Hurley E, Coutsoudis A, Giddy J, Knight S E, Loots E, Esterhuizen T M. Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. SAMJ. 2011;101 (9) : 645-650.

81. Idohou -Dossou N, Diouf A, Gueye AL, Guiro AT and S Wade, impact of daily consumption of Moringa oleifera dry leaf powder on iron status of Senegalese lactating women, African Journal of food, Agriculture, nutrition and development. 2011;11(3).

82. Jaiswal D, Kumar Rai P, Kumar A, Mehta S, Watal G, Effect of Moringa oleifera Lam.

leaves aqueous extract therapy on hyperglycemic rats, Journal of Ethno pharmacology.

2009; 123: 392 – 396.

83. Jane V. White, Guenter P, Jensen G, Malone A, Schofield M, Academy Malnutrition Work Group, A.S.P.E.N Malnutrition Task Force and the A.S.P.E.N Board of Directors, Consensus Statement : Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition : Characteristics Recommended for the Identification and Documentation of Adult Malnutrition(Under nutrition), JPEN JParenter Enteral Nutr. 2012; 36: 275.

84. Jensen GL, Bistrian B, Roubenoff R, Heimburger DC: Malnutrition syndromes: a conundrum vs continuum. JPEN J Parenter Enteral Nutr. 2009;33: 710-716.

85. Jensen GL, Mirtallo J, Compher C, et al. Adult starvation and disease-related

malnutrition: A rational approach for etiology-based diagnosis in the clinical practice

setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral

Nutr. 2010; 34 (2):156-159.

86. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis.

2008;8:52.

87. Katia Castetbon. Nutrition et infection par le VIH en Afrique: synthèse des connaissances vue par l’OMS, Transcriptase. Avril- mai. 2006;127: 8-11.

88. Katlama C, Deeks SG, Autran B, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013; 6736 (13);60104 - X.

89. Keusch G, The history of nutrition: malnutrition, infection and immunity. J. Nutr.

2003;133: S36–40.

90. King AJ, Levey AS, Dietary protein and renal function. J Am Soc Nephrol. 1993;

3(11):1723.

91. Koethe J, Chi BH, Megazinni KM, Heimburger DC, and Stringer JS: Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings. Clin Infect Dis 2009;29:787-98.

92. Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, Banda Y, Stringer JS. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2010; 53 (4): 507-13.

93. Koethe JR., Heimburger DC., Nutritional aspects of HIV-associated wasting in sub Saharan Africa. Am J Clin Nutr. 2010; 91(4): 1138S –1142S.

94. Kotler DP, Tiermey AR, Brenner SK, Couture S, Wang J, Pierson R. Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin. Nutr.

1989; 50: 444 - 7.

95. Kotler DP, Wang J, Pierson R, Studies of body composition in patients with the acquired Immunodeficiency syndrome. Am J Clin Nutr. 1985; 42:1255-65.

96. Kosmiski L. Energy expenditure in HIV infection, Am J Clin Nutr. 2011; 94 (6): 1677S -1682S.

97. Kritchevsky D, Shirley C. Chen, Phytosterols - health benefits and potential concerns: a

review, nutrition research, Nutrition Research, 2005. 5 (25):413 - 514.

98. Laah, J., & Ayiwulu, E. Socio-demographic characteristics of patients diagnosed with HIV/AIDS in Nasarawa Eggon. Asian Journal of Medical Sciences. 2010;2 (3):114 – 120.

99. Ladell K, Hashimoto M, Iglesias MC, Wilmann PG, McLaren JE, Gras S, Chikata T, Kuse N, Fastenackels S, Gostick E, Bridgeman JS, Venturi V, Arkoub ZA, Agut H, van Bockel DJ, Almeida JR, Douek DC, Meyer L, Venet A, Takiguchi M, Rossjohn J, Price DA, Appay V. A molecular basis for the control of preimmune escape variants by HIV- specific CD8+ T cells, Immunity. 2013; 38 (3): 425-36.

100. Lessells RJ et al. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4 cell count eligibility criteria. Journal of Acquired Immune Deficiency Syndromes. 2014; 65(1): e17- e24.

101. Li L, Wu S, Wu Z, Sun S, Cui H, & Jia M. Understanding family support for people living with HIV/AIDS in Yunnan, China. AIDS and Behavior. 2006;10 (5):509–517.

102. Loevinsohn M, Gillespie SR, HIV/AIDS, food security and rural livelihoods:

understanding and responding, discussion paper n°157, Washington, DC, ifpri.org, 2003.

[Page consultée le 14 janvier 2015]. [Disponible sur internet]:

http://www.ifpri.org/sites/default/files/pubs/divs/fcnd/dp/papers/fcndp157.pdf.

103. Lowell J. Fuglie, The Moringa tree, a local solution to malnutrition. [Page consultée le 17 avril 2015]. [Disponible sur internet]: http://miracletrees.org/moringa- doc/moringa_the_ miracle_tree.pdf .

104. Lusso P. HIV and the chemokine system : 10 years later. EMBO J. 2006; 25: 447 – 456.

105. Luzuriaga K, Tabak B, Garber M, Chen YH, Ziemniak C, McManus MM, Murray D, Strain MC, Richman DD, Chun TW5,Cunningham CK, Persaud D. HIV Type 1 (HIV-1) Proviral Reservoirs Decay Continuously Under Sustained Virologic Control in HIV-1- Infected Children Who Received Early Treatment, J Infect Dis. 2014; 210 (10): 1529 - 38.

106. Maas J, Dukkers N, Krol A, Van ameiden EJC, Van leeuwen R, Roos MTL, et al.

Body mass index course in asymptomatic HIV- infected homosexual men and the

predictive value of a decrease of body mass index for progression to AIDS. Journal of

acquired immune deficiency syndromes and Human retro virology. 1998;19:254 - 259.

107. Macallan DC, Margaret A, Nurlan MC, Milne E, Graham CA, Garlick PJ. Whole- body protein turnover from leucine kinetics and the response to nutrition in human immune deficiency virus infection, Am J Clin Nutr.1995; 61(4) : 818-826.

108. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward A, Sawyer MB, McManus TJ, Griffin GE. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995; 333(2): 83-88.

109. . Macallan, D, Noble, C, Baldwin, C, Foskett, M, McManus, T, & Griffin, G.

Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. American Journal of Clinical Nutrition, 58(3), 1993, pp. 417–424.

110. MacDonald J, Ndekha, Joep J, Gvan Oosterhout, Eduard E, Zijlstra, Micah Manary, Haroon Saloojee, Mark J Manary, Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial, BMJ. 2009;338:b1867.

111. . Mahlungulu SSN, Grobler L, Visser MME, Volmink J. Nutritional interventions for educing morbidity and mortality in people with HIV. Cochrane Database of systematic Revieuws 2007, Issue3, Art. N° CD004536.

112. . Makkar, H.P.S, Becker K, Nutrional value and antinutritional components of whole and ethanol extracted Moringa oleifera leaves, Animal Feed Science and Technology, 1996, 63 (1-4), 211–228.

113. Malim MH, Emerman M. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. Cell Host Microbe. 2008; 3: 388 -398.

114. . Malvy RD, Rodolphe T, Marimoutou C, Dabis F et al. Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults, Aquitaine cohort 1985-1997, France. Journal of the American College of Nutrition. 2001; 20, (6): 609 – 615.

115. Mangera TG, Maponga CC, prévalence and patterns of Moringa oleifera use amont HIV positive patients in Zimbabwe: cross section la survey, Journal of Public Health in Afrca. 2012; 3 (e6): 22-24.

116. Mangili A, Murman D H, Zampini A M, and Wanke CA, Nutrition and HIV Infection:

Review of Weight Loss and Wasting in the Era of Highly Active Antiretroviral Therapy

from the Nutrition for Healthy Living Cohort, HIV/AIDS : Clinical Infectious Disease.

2006:46.

117. Marcel C. résultats de l’enquête Retard : facteurs associés au retard d’accès aux soins.

Laboratoire de sociologie et d’anthropologie. Université Rennes 2, in : Journée de réflexion scientifique du groupe de travail inter associatif traitements et recherche thérapeutique (TRT-5), prise en charge tardive de l’infection à VIH, France, 24 mars 2006.

118. Mason JB. Lessons on nutrition of displaced people. J Nutr. 2002; 132:2096S-103S.

119. Matthew P, Fox M and Rosen S. Patient retention in antiretroviral therapy Programs up to three years on treatment in sub-Saharan Africa: 2007-2009, systematic review.

Tropical medicine and International Health. June 2010; 15 (s1): 1-15.

120. Mc Burney R. P H, Griffin C, Paul AA, Greenberg D C, The nutritional Composition of African wild food plants: from compilation to utilization. Journal of Food Composition and Analysis. 2004(17), 277-289.

121. Megazzini K, Washington S, Sinkala M, Lawson-Marriott S, Stringer E, Krebs D, Levy J, Chi B, Cantrell R, Zulu I, Mulenga L, Stringer J. A pilot randomized trial of nutritional supplementation in food insecure patients receiving antiretroviral therapy (ART) in Zambia. XVIème Conférence internationale sur le SIDA, Toronto, Canada, Août 2006.

122. Mehta LK, Balaraman R, Amin A.H, Bafna P.A, Gulati O.D, Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits, Journal of Ethnopharmacology, 2003 (86),2, 191–195.

123. Melchior J-C, Gelas P, Carbonnel F, Zazzo J-F, Henzel D, Cosnes J, Boulétreau P, Messing B, Improved Survival by Home total parenteral Nutrition in AIDS patients:

Follow-up of a controlled randomised prospective trial. AIDS. 1998; 12 (3): 336-337.

124. . Melchior, NiyongaboT, Henzel D et Al. malnutrition and wasting immunodepression

and chronic inflammation as independent predictors of survival in HIV- infected

patients. Nutrition. 1999; 15: 865-9.

125. Melchior JC., De Truchis P., aspects nutritionnels de l’infection à VIH: de la dénutrition aux syndromes lipodystrophiques in : Girard PM., Katlama C., Pialoux G : VIH édition 2001. Doin éditeurs, paris. 2001:253-254.

126. Messou E, Gabillard D, Moh R, Inwoley A, Sorho S, Eholié S, Rouet F, Seyler C, Danela C, Anglaret X. Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults, Bulletin of the World Health Organization | June. 2008; 86 (6): 435 – 442.

127. Ministère du Plan, Institut National de la Statistique en collaboration avec Le Fonds des Nations Unies pour l’Enfance (UNICEF), [Page consultée le 12 janvier 2015].

Enquête par grappes à indicateurs multiples MICS RDC 2010, [Disponible sur internet] : http://www.unicef.org/drcongo/french/MICS_RDC_2010.pdf.

128. Ministère de la santé publique, Pronanut, Plan national de développement sanitaire en République nationale du Congo, volet nutrition, 2011 - 2015. [Page consultée le 16 avril

2015]. [Disponible sur internet] :

www.reliefweb.int/sites/reliefweb.int/files/resources/Situation_Report_259.pdf.

129. Ministère de la santé, programme national de la lutte contre le VIH et les ISTs, guide national de la prise en charge de l’infection à VIH en R.D.C, Révision juillet 2013, [Page consultée le 03 mars 2015]. [disponible sur internet] : www.emtct-iatt.org/.../RDC- Guide-Intégrateur-des-PVVIH-Aout-2013-V.

130. Ministère de la santé, Secrétariat général à la santé, Programme national d’approvisionnement en Médicament essentiels, Plan stratégique 2008 consulté sur : http://www.asrames.com/wp-content/uploads/2012/04/PNAM-Plan-Strategique-2008-2- 2012.pdf.

131. Ministère de la santé, secrétariat général de la santé, Prise en charge intégré de la malnutrition Aigue(PCIMA), R.D.C. 2012. [Page consultée le 10 février 2014].

[Disponible sur internet] :

http://reliefweb.int/sites/reliefweb.int/files/resources/Situation_Report_258.pdf.

132. Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S,

Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F,

Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A,

Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle

R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μl in the post-combination antiretroviral therapy era. Clin Infect Dis. 2013; 57 (7) :1038 - 1047.

133. Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu. Rev.

Pathol. 2011; 6: 223-248.

134. Monnier L, Nutrition : balance azotée et balance énergétique chez le sujet alité en pathologie intercurrente Journal des Plaies et Cicatrisations n° 7 – Mai 1997.

135. Moore. DM, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, et al. Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy. J Acquir Immune Defic Syndr. 2005; 40 (3): 288-293.

136. Moummi, Ahmed, Analyse de la pauvreté en République Démocratique du Congo, Working Papers Séries, 2010, N° 112, African Development Bank, Tunis, Tunisia. [Page consultée le 15 janvier 2015] [Disponible sur internet] : https://ideas.repec.org/p/adb/adbwps/987.htm.

137. . Mulligan K.V.W, Tai, and Schamberlan M. Energy expenditure in Human Immunodeficiency virus infection. N. Engl. J. Med.1997; 336:70-71.

138. Muñoz C, Schlesinger L, Cavaillon JM, Interaction between cytokines, nutrition and infection, Nutrition Research, 1995 (15)12:1815-1844.

139. Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, et al. ‘‘If I have nothing to eat, I get angry and push the pills bottle away from me’’: A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care, 2013; 25(10):1271-7.

140. Musumari PM, Wouters E, Kayembe PK, Nzita MK, Mbikayi SM, S. Suguimoto P, Techasrivichien T, Lukhele BW, El-saaidi C, Piot P, Kihara MO, Kihara M. Food Insecurity is associated with increased risk of non-adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo. Plos one. 2014 (9)1:

e85327.

141. Murray LK, Semrau K, Mc Curley E et al, Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS care:

Psychological and Socio-medical Aspects of AIDS/HIV. 2009; 21(1):78-86.

142. Murielle M K. épidémiologie de la prise en charge tardive, Inserm (Paris) in : Journée de réflexion scientifique du groupe de travail inter associatif traitements et recherche thérapeutique (TRT-5), prise en charge tardive de l’infection à VIH, France, 24 mars 2006.

143. Nachega JB, Knowlton AR, Deluca A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006; 43 (Suppl 1):S127- 33.

144. Nadhiroh, S. Good nutrition for quality of life of PLWHA (People Living with HIV/AIDS). The Indonesian Journal of Public Health. 3(2), 2006, pp. 29-34.

145. Nahlen BL, Chu SY, Nwanyanwu RL, Berkelman RL, Martinez SA, Rulian JV. HIV- Wasting syndrome in United States, J. acquired Immune Defic. Syndr.1993; 7:183-8.

146. Nakamura H, Ito S, Ebe N, Shibata, renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care. 1993; 16(8):1071.

147. Nadro, M.S., Arungbemi, R.M. and Dahiru, D, Evaluation of Moringa oleifera Leaf Extract on Alcohol-induced Hepatotoxicity, Trop J Pharm Res,J. 2006; 5 (1): 539 -544.

148. National Alliance for Infusion Therapy and the American Society for Parenteral and Enteral Nutrition Public Policy Committee and Board of Directors. Disease-related malnutrition and enteral nutrition therapy: A significant problem with a cost-effective solution. Nutr Clin Pract. 2010; 25 (5):548-554.

149. Negassie Berhe, Desalegn Tegabu and Mekuriaw Alemayehu, Effect of nutritional factors on adherence to antiretroviral therapy among HIV-infected adults: a case control study in Northern Ethiopia, BMC Infectious Diseases. 2013,13: 233.

150. Nettles RE., Kieffer TL., Kwon P et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA, 2005, (293): 817 - 829.

151. . Ndong M, Wade S, Dossou N, Guiro T.A, Gning R.D, valeur nutritionnelle du

Moringa oleifera, étude de la biodisponibilité du Fer, effet de l’enrichissement de divers

plats traditionnels sénégalais avec la poudre des feuilles, African Journal of Food Agriculture Nutrition and Développement: 2007 (7) 3.

152. Niyongabo T, Bouchaud O, Henzel D, Melchior JC, Samb B, Dazza MC, Ruggeri C, Begue JC, Coulaud JP, Larouze B. nutritional status of HIV- seropositive subjects in an AIDS clinic in Paris. Eur. J.Clin. Nutr. 1997; 51(9): 637- 40.

153. Niyongabo T, Henzel D, Ndayishimyie JM, Melchior JC, Ndayiragije A, Ndihokubwayo, Rwasa T, Aubry P, Larouze B. Nutritional status of adult inpatients in Bujumbura, Burundi (impact of HIV infection, Eur J Clin Nutr. 1999 Jul; 53(7):579 -82.

154. OMS, [Page consultée le 03/02/2015]. Besoins en nutriments des personnes vivant avec le VIH/sida : rapport d’une consultation technique, Genève, 13–15 mai 2003.

[Disponible sur internet] :

http://www.who.int/nutrition/publications/hivaids/9789242591194_fre.pdf.

155. OMS, [Page consultée le 29/01/2015]. VIH/sida, Aide-mémoire N°360, Décembre 2014. [Disponible sur internet] ; www.who.int/mediacentre/factsheets/fs360/fr/.

156. OMS, [Page consultée le 29/09/2017]. VIH/sida, Aide-mémoire, Actualisé en juillet 2017. [Disponible sur internet] : www.who.int/mediacentre/factsheets/fs360/fr/.

157. ONUSIDA, [Page consultée le 29/09/2017]. fiche d'information — Dernières statistiques sur l'état de l'épidémie de sida. [Disponible sur internet] : http://www.unaids.org/fr/resources/fact-sheet.

158. ONUSIDA 2013, [Page consultée le 29/01/2015]. Le sida en chiffres, [Disponible sur

internet] : www.unaids.org/sites/default/files /media

asset/JC2571_AIDS_by_the_numbers_fr_1.

159. ONUSIDA.[Page consultée le 02 mai 2014]. Rapport mondial 2013.[disponible sur internet :

http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2 013/UNAIDS_Global_Report.

160. Organisation des Nations Unies pour l’alimentation et l’agriculture, [Page consultée le

10 janvier 2014]. L’état de l’insécurité alimentaire dans le monde, Viale delle Terme di

Caracalla, 00153. Rome, Italie. [Disponible sur internet] : www.fao.org,

161. Ott M, Lembcke B, Fischer H et all. Early changes of body composition in Human Immunodeficiency virus-infected patients: tetra polar body impedance analysis indicates significant malnutrition, Am J. Clin. Nutr. 1993; 57:15 - 9.

162. Paton, N., Sangeetha, S., Earnest, A., & Bellamy, R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Medicine, 2006 ;7(5) :323–330.

163. Patrice M. Les risques à court et long termes d’une prise en charge tardive de l’infection à VIH, centre Hospitalier de Purpan (Toulouse) in : Journée de réflexion scientifique du groupe de travail inter associatif traitements et recherche thérapeutique (TRT-5), prise en charge tardive de l’infection à VIH. France. 24 mars 2006.

164. Paulus JJ, Stratégies de lutte in : nutrition de la théorie à la pratique, par Tandu-Umba N.F.B, presses de l’Université de Kinshasa, 2001.

165. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M, Chun TW, Strain M, Richman D, and ne Luzuriaga K, Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant, N Engl J Med 2013; 369:1828 - 1835.

166. Piwoz E. et al. Note d’orientation du projet soutien pour l’Analyse et la recherche en Afrique (SARA) et projet d’Assistance technique pour l’Alimentation et la Nutrition (FANTA), Juin 2004.

167. Programme National de Lutte contre VIH/Sida (PNLS) et World Food Program, Prise en charge nutritionnelle des PVVIH dans 8 villes de la République Démocratique du Congo : Le point et les perspectives, rapport d’enquête, Avril 2013. Non publié.

168. UNGASS–République Démocratique du Congo. Rapport national session Extraordinaire de l’assemblée générale des Nations Unies sur le sida, 2010.

169. .UNAIDS [Page Accessed 12 June, 2012]. World AIDS day report.2011. [Available

on internet]:

www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC22 16.

170. Rabaud C, Tronel H, Fremont S, May T, Canton P, Nicolas JP. Free radicals and HIV

infection, Ann Biol Clin 1997; 55 (6):565-71.

171. ONUSIDA. [Page consultée le 1èr décembre 2011]. Rapport Journée Mondiale SIDA.

ONUSIDA. 2010. [Disponible sur internet] : www.unaids.org.

172. OMS. [Page consultée le 22 mai 2009]. Rapport de L’OMS et de l’ONUSIDA .Vers un accès universel : Etendre les interventions prioritaires liées au VIH/SIDA dans le secteur de la santé : Organisation mondiale de la santé, ONUSIDA, UNICEF. mars

2007.[Disponible sur internet] :

http://www.who.int/hiv/mediacentre/universal_access_progress_report_fr.pdf.

173. Rapport général, Journée de réflexion scientifique du groupe de travail inter associatif traitements et recherche thérapeutique (TRT-5), prise en charge tardive de l’infection à VIH. France 24 mars 2006.

174. Rapport synthèse de la revue du programme VIH en R D Congo, Kinshasa, PNMLS, Août 2013 non publié.

175. RDC. [Page consultée le 25 juin 2015]. République démocratique du Congo, Ministère du plan et suivi de la mise en œuvre de la révolution de la modernité, Rapport Global, Enquête 1–2–3, Institut National de la Statistique, septembre 2014. [disponible sur internet] : http://www.insrdc.org/sites/default/files/Rapport%20enquete%20123.pdf.

176. RIGAUD D. nutrition et immunité, Service de Gastro-entérologie et Nutrition, Hôpital BICHAT- PARIS, France. [Page consultée le 10/05/2014]. [Disponible sur internet] : http://www.institutdanone.org/objectif-nutrition/nutrition-et-immunite/dossier-nutrition- et-immunite/.

177. Robert C, Kalayjian, The Treatment of HIV-Associated Nephropathy, adv Chronic Kidney Dis.2010;17(1): 59-71.

178. Robyns W. Comité exécutif du Congo Belge et le jardin Botanique de l’État, Flore du Congo Belge et du Ruanda-Urundi, Spermatophytes II, publications de l’institut national pour l’étude agronomique du Congo Belge(I.N.EA.C), National Botanic Garden of Belgium, Bruxelles. 1951.

179. Routy JP, mini lecture: l’immunothérapie, royal victoria hôpital, Montréal, 7

conférence internationale francophone VIH/hépatites, AFRAVIH, Montpellier 2014.

180. Rosen S, Fox MP, Gill CJ Patient Retention in Antiretroviral Therapy Programs in

Sub-Saharan Africa: A Systematic Review. PLoS Med. 2007; 4(10): e298.

181. Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, et al. Post- Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study. PLoS Pathog. 2013, 9 (3): e100321.

182. Saint Sauveur A et Broin M. [Page consultée le 24 avril 2015]. Dans produire et transformer les feuilles de Moringa, CTA. 2010. [Disponible sur internet] : http://www.anancy.net/index.php?

specific=freetext_search&destination=freetext&freetext=Moringa

%20&files=yes&file_id=13065&language=french.

183. Scarcella P, Buonomo E, Zimba I, Doro Altan AM, Germano P, Palombi L, Marazzi MC, The impact of integrating food supplementation, nutritional education and HAART (Highly Active Antiretroviral Therapy) on the nutritional status of patients living with HIV/AIDS in Mozambique: results from the DREAM Programme, Ig Sanita Pubbl.

2011; 67(1):41-52.

184. Schaible UE, Kaufmann SHE Malnutrition and infection: Complex mechanisms and global impacts. PLoS Med 2007, 4 (5): e115.

185. Schechter M, Tuboi SH. Discordant immunological and virological responses to antiretroviral therapy. J Anti microb. Chemo ther 2006; 58 (3):506

186. Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Ringlet C, Mojica W, Newberry S. Antiretroviral (ARV) Drug Resistance in the Developing World. Evidence Report/Technology Assessment. Rockville, MD: Agency for Healthcare Research and Quality. 2007.[Page accessed on June 2010]. [Available on internet]: https://archive.ahrq.gov/downloads/pub/evidence/pdf/antiretro/antiret.pdf.

187. Schwenk A, Büger B, Wessel D, Stützer H, Ziegenhagen D, Diehl V, Schrappe M.

Clinical risk factors for malnutrition in HIV-1 Infected patients. AIDS. 1993; 7(9): 1213 - 1219.

188. Sharp PM, Hahn BH, Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011; 1(1): a 006841.

189. Scott V. Digesdahl digestion apparatus, sample preparation for protein and elemental

analysis, technical information series-blocklet n°14. [Page consultée le 12 mai 2012].

Isponible sur internet]: https://www.hach.com/digesdahl-digestion-apparatus-115- vac/product-downloads?id=7640450051.

190. Sicault J.D, Kiss A.C, La Conférence des Nations Unies sur l'environnement, Stockholm, annuaire français de droit international. 1972 (18) ; 603-628.

191. Simone E, Langford, Jintanat Ananworanich, David A, Cooper, Predictors of disease progression in HIV infection: a review, Aids Research and Therapy 2007 (4):11.

192. Somarriba G, Neri D, Schaefer N, L Miller T, The effect of aging, nutrition, and exercise during HIV infection. HIV/AIDS-Research and Palliative Care. 2010;2:191-201 193. Sow, K., & Desclaux, A. La solidarité familiale dans la prise en charge des patients:

réalités, mythes et limites: dans l’initiative sénégalaise d’accès aux médicaments antirétroviraux : analyses économiques, sociales, comportementales et médicales, ANRS, collection sciences sociales et sida, Paris. 2002 :79- 93.

194. Sundquist WI, Kräusslich H-G. HIV-1 Assembly, Budding, and Maturation. Cold Spring Harb Perspect Med. 2012; 2 (7): a006924.

195. Suttmann U, Ockenga J, Selberg O, et al, Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus–infected Outpatients Acquir. Immune Defic. Syndr. Hum. Retroviral. 1995; 8:239-246.

196. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006; 296:782 – 93.

197. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 2010; 376(9738):340-345.

198. Tami-Maury I, Willig J, Jolly P, Sten H, Vermund, Aban I, Hill J, and Craig M,

Wilson, Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on

Antiretroviral Therapy. ISRN Infectious Diseases. 2013; 126 (10):887-93.

199. Tandu-Umba N.F.B, nutrition de la théorie à la pratique, presses de l’Université de Kinshasa, 2001.

200. Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, Wanke C.

Micronutrients: current issues for HIV care providers. AIDS. 2005; 19 (9): 847- 61.

201. Tang A, Forrester J, Spiegelman D, Knox T, Tchetgen E., & Gorbach S. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy.

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002; 31(2): 230–236.

202. Tang AM, Graham NM, Kirby AJ, McCall LD, Willett WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men.

Am J Epidemiol. 1993 1;138 (11): 937-51.

203. Tang AM, Graham NM, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol. 1996;143 (12):1244-56.

204. Tété Bénissan A, Quashie AML, Lawson K, Gnandi K, Kokou K and Gbéassor M, Influence of Moringa oleifera leaves on atherogenic lipids and glycaemia evolution in HIV-infected and uninfected malnourished patients, Journal of Applied Biosciences 62:

4610 – 4619.

205. Tete–Benissan A, Quashie M, Lawsonevi K, Kokou K, Gbeassor M, Récupération nutritionnelle chez les sujets malnutris VIH positifs et VIH négatifs après utilisation de feuilles de Moringa oleifera Lam, Journal of Animal & plant Sciences, 2012 :15(2) : 2184-2199.

206. Tiyou et al.: Food insecurity and associated factors among HIV-infected individuals receiving highly active antiretroviral therapy in Jimma zone Southwest Ethiopia.

Nutrition Journal 2012 11:51.

207. Thurber M.D and Jed W. Fahey. Adoption of Moringa oleifera to combat under- nutrition viewed through the lens of the “Diffusion of Innovations” theory, Ecol. Food Nutr. 2009, 48(3): 212–225..

208. Tollens Eric: L’Etat actuel de la sécurité alimentaire en RD Congo: Diagnostic et

perspectives, Département d’Economie agricole et de l’environnement, KU Leuven,

Working Paper, 2003/77, [Page consultée le 23 décembre 2013]. [Disponible sur internet]: http://www.biw.kuleuven.be/aee/clo/wp/tollens2003a.pdf.

209. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, Diakite N, Karcher S, Grundmann C, Marlink R, Dabis F, Anglaret X; Aconda Study Group. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants. AIDS. 2008; 22(7): 873 - 82.

210. Tshingani K, Schirvel C, Mukumbi H, Wilmet-Dramaix M. L’évolution du poids des personnes vivant avec le VIH suivies sous antirétroviraux à Kinshasa, revue de l’U.KA, 2013 (2).

211. Tshingani K, Schirvel C, Mukumbi H, Ngambwe S, Wilmet-Dramaix M.

Vulnerability factors for malnutrition among people living with HIV under antiretroviral treatment in an outpatient clinic: Kinshasa, Democratic Republic of Congo. HIV &

AIDS Review. 2013 (12), issue 4.

212. UE, Un cadre stratégique de l’UE pour aider les pays en développement à relever les défis, communication de la commission européenne au conseil et parlement européen, SEC. (2010) 379. [Page consultée le 20 janvier 2011]. [Disponible sur internet] : http://www.europarl.europa.eu/meetdocs/2009_2014/documents/com/com_com(2010)01 27_/com_com(2010)0127_fr.pdf.

213. Ulrich E. Schaible, Stefan H. E. Kaufmann, Malnutrition and Infection: Complex Mechanisms and Global Impacts, PLoS Medicine, May 2007(4)5: e115.

214. UNGASS-République Démocratique du Congo. Rapport national session Extraordinaire de l’assemblée générale des Nations Unies sur le sida, 2010.

215. Van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, et al. Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1. PLoS Med. 2004; 1(1): e19.

216. Van der Sande, Marianne AB, van der Loeff, Maarten F, Schim, Aveika, Akum A,

Sabally, Saihou, Togun, Toyin, Sarge-Njie, Ramu, Alabi, Abraham S, Jaye, Assan,

Corrah, Tumani, Whittle, Hilton C Less. Body Mass Index at Time of HIV Diagnosis: A

Strong and Independent Predictor of Survival. JAIDS Journal of Acquired Immune

Deficiency Syndromes. 2004; (37) 2: 1288-1294.

217. Von Grebmer K, Headey D, Olofinbiyi T, Wiesmann D, Fritschel H, Yin S, Yohannes Y, Thompson J, Von Oppeln C, Rahall J, 2013, Indice de la faim dans le monde : Le défi de la faim : Construire la résilience pour une sécurité alimentaire et nutritionnelle durable. Publisher: Deutsche Welthungerhilfe (German AgroAction); International Food Policy Research Institute (IFPRI); Concern Worldwide: Bonn, Germany, Washington, D.C, Dublin, Ireland. [Page consultée le 23 décembre 2013]. [Disponible sur internet] : http://www.ifpri.org/sites/default/files/publications/ghi13fr.pdf.

218. Walmsley, S. (2006) Update on antiretroviral treatment failure and the management of treatment-experienced HIV-infected patients. In: Optimizing therapy for patients with multidrug-resistant HIV–part II, review and updates to the 2005 ICAAC Satellite Symposium, management of treatment–experienced Patients. Available at www.thebody.com [Accessed 20 June, 2012].

219. Wanke C. A, Silva M, Knox T. A, Forrester J, Speigelman D, and. Gorbach S. L, Brief Reports, Clinical infectious disease 2000;31 consulted on http://cid.oxfordjournals.org/

on December 9, 2014.

220. WHO report in partnership, with UNICEF and UNAIDS, HIV TREATMENT: Global update on HIV treatment 2013: Results, Impact and Opportunities, June 2013. [Page consultée le 08 octobre 2014]. [Disponible sur internet] : http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2 0 13/UNAIDS_Global_Report.

221. Williams SB, Bartsch G, Muurahainen N, Collins G, Raghavan SS, Wheeler D.

Protein intake is positively associated with body cell mass in weight-stable HIV-infected men. J Nutr. 2003: 133: 1143–1146.

222. Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008; 47 (11):1449-57

223. World Food and Nutrition Technical Assistance (FANTA) Project and World Food Program (WFP). Food Assistance Programming in the Context of HIV. Washington, DC: FANTA Project, Academy for Educational Development (WFP). 2007.

224. World Hunger Education, Hunger notes: Africa Hunger and Poverty Facts. [Page consultée le 17 janvier 2015]. [Disponible sur internet] :

http://www.worldhunger.org/articles/ Learn/africa hunger_ _facts.htm.

225. World Health organization. [Page accessed on May 15, 2007]. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894, Geneva. 2000. [Avalable on internet] :

http://www.who.int/nutrition/publications/obesity/WHO_TRS_894/fr/.